CPEX: Summary for CPEX Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 6:27am EST - Canadian Markets open in 3 hours and 3 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

CPEX Pharmaceuticals, Inc. (CPEX)

On Nov 24: 11.00 USD 0.00 (0.00%)

MORE ON CPEX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CPEX Pharmaceuticals, Inc. (NCM:CPEX) Delayed quote data

Last Trade:	11.00 USD
Trade Time:	Nov 24
Change:	0.00 (0.00%)
Prev Close:	11.00
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	5.90 - 12.58
Volume:	0
Avg Vol (3m):	2,575.76
Market Cap:	27.96M
P/E (ttm):	N/A
EPS (ttm):	-0.90
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y

Add CPEX to Portfolio

Download Data

HEADLINES

•	CPEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Thu, Nov 12)

•	CPEXs Nasulin Insulin Therapy Featured in an Oral Presentation and Four Abstracts at the Ninth Annual Diabetes Technology Meeting
	Business Wire (Thu, Nov 5)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Wed, Nov 4)

•	CPEX Pharmaceuticals Reports Third-Quarter 2009 Financial Results
	Business Wire (Wed, Nov 4)

•	CPEX Pharmaceuticals to Present at Ninth Annual Diabetes Technology Meeting
	Business Wire (Tue, Sep 15)

•	CPEX PHARMACEUTICALS, INC. Financials
	EDGAR Online Financials (Wed, Aug 26)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 14)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition
	EDGAR Online (Wed, Aug 5)

•	Insiders Sell $31.8M Worth of Boston Properties
	at TheStreet.com (Thu, Jul 30)

•	CPEX PHARMACEUTICALS, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant
	EDGAR Online (Wed, Jun 24)

More Headlines for CPEX...

ANALYST

EPS Est (next year) (Dec-09) :	N/A
EPS Est (in 2 years) (Dec-10) :	N/A
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

CPEX Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development, licensing, and commercialization of pharmaceutical products utilizing its validated drug delivery technology.

Full Company Profile

Add to Portfolio

Email to a Friend

•